The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open label, multicenter phase 2 study to evaluate the efficacy of sorafenib in patients (pts) with advanced Renal Cell Carcinoma (RCC) after a radical resection of the metastases.
 
Elena Verzoni
Speakers' Bureau - Janssen; Novartis; Pfizer
 
Paolo Grassi
No Relationships to Disclose
 
Rosanna Montone
No Relationships to Disclose
 
Claudia Maggi
No Relationships to Disclose
 
Francesco Cognetti
No Relationships to Disclose
 
Michele Milella
No Relationships to Disclose
 
Alessandra Bearz
No Relationships to Disclose
 
Cinzia Ortega
No Relationships to Disclose
 
Franco Morelli
No Relationships to Disclose
 
Vincenzo Emanuele Chiuri
No Relationships to Disclose
 
Andrea Necchi
No Relationships to Disclose
 
Filippo G. De Braud
No Relationships to Disclose
 
Giuseppe Procopio
Honoraria - Astellas Pharma; GlaxoSmithKline; Janssen; Pfizer
Consulting or Advisory Role - Janssen